Actively Recruiting
Assess Accuracy of Primary Care Asthma and COPD Diagnosis Using Oscillometry and FeNO vs Specialist Diagnosis
Led by AstraZeneca · Updated on 2026-04-21
600
Participants Needed
12
Research Sites
70 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Current diagnostic methods for asthma and chronic obstructive pulmonary disease mostly depend on pulmonary function tests, especially spirometry. While spirometry is a foundational tool, its diagnostic accuracy is often limited by the patient's ability to perform forceful breathing maneuvers, as well as technical and reproducibility challenges, and the need for proper equipment and training. These constraints can compromise effective diagnosis of asthma and COPD in primary care settings. Prompt and accurate diagnosis by primary care physicians is essential for better patient outcomes. Although variable airflow limitation often measured as a change in FEV1 after bronchodilator is a hallmark of asthma, inconsistencies in test quality and reversibility criteria create challenges in distinguishing asthma from COPD. These complexities highlight the need for alternative diagnostic tools beyond traditional spirometry. This observational study is designed to evaluate the diagnostic accuracy and technical feasibility of using oscillometry and FeNO testing in primary care for suspected asthma and COPD, compared to conventional specialist-based diagnostics. The study will be conducted across 6 countries in the MEA, Asia, and Latin America, with two hospital sites per country. Primary care physicians will be trained in oscillometry and FeNO testing using standardized protocols and tools such as the Ambulatory Lung Diagnosis System following GINA and GOLD guidelines. Eligible patients will provide consent, complete a history and symptom questionnaire, and undergo primary care-based assessment for a provisional diagnosis. If specialist assessment cannot occur the same day, it will be done within three days. No follow-up visits are planned. Study outcomes will inform the feasibility and accuracy of integrating these methods into routine care, aiming to improve the early and reliable diagnosis of asthma and COPD.
CONDITIONS
Official Title
Assess Accuracy of Primary Care Asthma and COPD Diagnosis Using Oscillometry and FeNO vs Specialist Diagnosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 18 years or older (or legal age of consent) with suspected asthma symptoms but no confirmed diagnosis
- Patients 40 years or older with suspected COPD symptoms but no confirmed diagnosis
- Patients capable of providing written informed consent
You will not qualify if you...
- Prior diagnosis of asthma or COPD
- Use of inhaled corticosteroids in the last 6 months or oral corticosteroids in the last 3 months
- Presence of diseases affecting lung function such as lung cancer, pneumonia, active tuberculosis, pulmonary embolism, or interstitial lung disease
- Recent surgery affecting lung function, including thoracotomy, pneumothorax surgery, or thoracic drainage
- Contraindications to spirometry or oscillometry tests or allergy to bronchodilator
- Current pregnancy or breastfeeding
- Patients unlikely to comply with study procedures or requirements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 12 locations
1
Research Site
Buenos Aires, Argentina
Actively Recruiting
2
Research Site
Medoza, Argentina
Actively Recruiting
3
Research Site
Alexandria, Egypt
Not Yet Recruiting
4
Research Site
El Waili, Egypt
Not Yet Recruiting
5
Research Site
Monterrey, Mexico
Not Yet Recruiting
6
Research Site
Santiago de Quer Taro, Mexico
Not Yet Recruiting
7
Research Site
Riyadh, Saudi Arabia
Not Yet Recruiting
8
Research Site
Taichung, Taiwan
Not Yet Recruiting
9
Research Site
Taoyuan City, Taiwan
Not Yet Recruiting
10
Research Site
Dubai, United Arab Emirates
Not Yet Recruiting
11
Research Site
Hanoi, Vietnam
Not Yet Recruiting
12
Research Site
Ho Chi Minh City, Vietnam
Not Yet Recruiting
Research Team
A
AstraZeneca Clinical Study Information Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here